nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Mitomycin—stomach cancer	0.221	0.581	CbGbCtD
Scopolamine—ABCB1—Irinotecan—stomach cancer	0.0567	0.149	CbGbCtD
Scopolamine—ABCB1—Docetaxel—stomach cancer	0.0416	0.109	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—stomach cancer	0.031	0.0815	CbGbCtD
Scopolamine—ABCB1—Methotrexate—stomach cancer	0.03	0.0789	CbGbCtD
Scopolamine—CHRM3—muscle of abdomen—stomach cancer	0.0186	0.334	CbGeAlD
Scopolamine—SI—pancreas—stomach cancer	0.00914	0.164	CbGeAlD
Scopolamine—SI—digestive system—stomach cancer	0.00781	0.14	CbGeAlD
Scopolamine—CHRM5—epithelium—stomach cancer	0.00396	0.0712	CbGeAlD
Scopolamine—CHRM3—smooth muscle tissue—stomach cancer	0.00213	0.0383	CbGeAlD
Scopolamine—ABCB1—blood vessel—stomach cancer	0.00177	0.0318	CbGeAlD
Scopolamine—CHRM2—endocrine gland—stomach cancer	0.00171	0.0307	CbGeAlD
Scopolamine—CHRM3—digestive system—stomach cancer	0.00168	0.0303	CbGeAlD
Scopolamine—CHRM1—endocrine gland—stomach cancer	0.00156	0.0279	CbGeAlD
Scopolamine—CHRM3—endocrine gland—stomach cancer	0.00139	0.025	CbGeAlD
Scopolamine—Thirst—Capecitabine—stomach cancer	0.00137	0.00428	CcSEcCtD
Scopolamine—Nausea—Mitomycin—stomach cancer	0.00131	0.00409	CcSEcCtD
Scopolamine—Visual impairment—Irinotecan—stomach cancer	0.0013	0.00405	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—stomach cancer	0.00129	0.00403	CcSEcCtD
Scopolamine—Pharyngitis—Fluorouracil—stomach cancer	0.00128	0.004	CcSEcCtD
Scopolamine—Flushing—Irinotecan—stomach cancer	0.00125	0.0039	CcSEcCtD
Scopolamine—Irritability—Capecitabine—stomach cancer	0.00125	0.00388	CcSEcCtD
Scopolamine—Urinary retention—Capecitabine—stomach cancer	0.00124	0.00387	CcSEcCtD
Scopolamine—Dry skin—Docetaxel—stomach cancer	0.00124	0.00385	CcSEcCtD
Scopolamine—Arrhythmia—Irinotecan—stomach cancer	0.00121	0.00376	CcSEcCtD
Scopolamine—Dry skin—Capecitabine—stomach cancer	0.0012	0.00373	CcSEcCtD
Scopolamine—Dysphagia—Docetaxel—stomach cancer	0.00117	0.00363	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—stomach cancer	0.00116	0.00361	CcSEcCtD
Scopolamine—Arrhythmia—Fluorouracil—stomach cancer	0.00116	0.0036	CcSEcCtD
Scopolamine—Muscular weakness—Capecitabine—stomach cancer	0.00115	0.00359	CcSEcCtD
Scopolamine—Dysphagia—Capecitabine—stomach cancer	0.00113	0.00352	CcSEcCtD
Scopolamine—Erythema—Fluorouracil—stomach cancer	0.00113	0.00351	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—stomach cancer	0.00107	0.00334	CcSEcCtD
Scopolamine—Vision blurred—Fluorouracil—stomach cancer	0.00106	0.0033	CcSEcCtD
Scopolamine—Vertigo—Irinotecan—stomach cancer	0.00106	0.00329	CcSEcCtD
Scopolamine—Dysuria—Capecitabine—stomach cancer	0.00106	0.00329	CcSEcCtD
Scopolamine—Eczema—Epirubicin—stomach cancer	0.00101	0.00315	CcSEcCtD
Scopolamine—Conjunctivitis—Docetaxel—stomach cancer	0.00101	0.00315	CcSEcCtD
Scopolamine—Conjunctivitis—Capecitabine—stomach cancer	0.000979	0.00305	CcSEcCtD
Scopolamine—Confusional state—Irinotecan—stomach cancer	0.000967	0.00301	CcSEcCtD
Scopolamine—Oedema—Irinotecan—stomach cancer	0.000959	0.00299	CcSEcCtD
Scopolamine—ABCB1—hematopoietic system—stomach cancer	0.000942	0.0169	CbGeAlD
Scopolamine—Nervous system disorder—Irinotecan—stomach cancer	0.000941	0.00293	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—stomach cancer	0.000937	0.00292	CcSEcCtD
Scopolamine—Irritability—Methotrexate—stomach cancer	0.000928	0.00289	CcSEcCtD
Scopolamine—Hyperhidrosis—Irinotecan—stomach cancer	0.000927	0.00289	CcSEcCtD
Scopolamine—Confusional state—Fluorouracil—stomach cancer	0.000927	0.00289	CcSEcCtD
Scopolamine—Pharyngitis—Docetaxel—stomach cancer	0.000926	0.00289	CcSEcCtD
Scopolamine—Urinary tract disorder—Docetaxel—stomach cancer	0.000922	0.00287	CcSEcCtD
Scopolamine—Bradycardia—Capecitabine—stomach cancer	0.00092	0.00287	CcSEcCtD
Scopolamine—Oedema—Fluorouracil—stomach cancer	0.000919	0.00286	CcSEcCtD
Scopolamine—Urethral disorder—Docetaxel—stomach cancer	0.000915	0.00285	CcSEcCtD
Scopolamine—Nervous system disorder—Fluorouracil—stomach cancer	0.000901	0.00281	CcSEcCtD
Scopolamine—Visual impairment—Docetaxel—stomach cancer	0.0009	0.0028	CcSEcCtD
Scopolamine—Pharyngitis—Capecitabine—stomach cancer	0.000897	0.00279	CcSEcCtD
Scopolamine—Tachycardia—Fluorouracil—stomach cancer	0.000897	0.00279	CcSEcCtD
Scopolamine—Hypotension—Irinotecan—stomach cancer	0.000896	0.00279	CcSEcCtD
Scopolamine—Urinary tract disorder—Capecitabine—stomach cancer	0.000893	0.00278	CcSEcCtD
Scopolamine—Urethral disorder—Capecitabine—stomach cancer	0.000886	0.00276	CcSEcCtD
Scopolamine—Eye disorder—Docetaxel—stomach cancer	0.000872	0.00272	CcSEcCtD
Scopolamine—Visual impairment—Capecitabine—stomach cancer	0.000871	0.00271	CcSEcCtD
Scopolamine—Flushing—Docetaxel—stomach cancer	0.000866	0.0027	CcSEcCtD
Scopolamine—ABCB1—epithelium—stomach cancer	0.000861	0.0155	CbGeAlD
Scopolamine—Hypotension—Fluorouracil—stomach cancer	0.000859	0.00267	CcSEcCtD
Scopolamine—Somnolence—Irinotecan—stomach cancer	0.000853	0.00266	CcSEcCtD
Scopolamine—Eye disorder—Capecitabine—stomach cancer	0.000845	0.00263	CcSEcCtD
Scopolamine—Flushing—Capecitabine—stomach cancer	0.000839	0.00261	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—stomach cancer	0.000834	0.0026	CcSEcCtD
Scopolamine—Arrhythmia—Docetaxel—stomach cancer	0.000834	0.0026	CcSEcCtD
Scopolamine—Fatigue—Irinotecan—stomach cancer	0.000827	0.00258	CcSEcCtD
Scopolamine—Pain—Irinotecan—stomach cancer	0.00082	0.00256	CcSEcCtD
Scopolamine—Constipation—Irinotecan—stomach cancer	0.00082	0.00256	CcSEcCtD
Scopolamine—Mental disorder—Docetaxel—stomach cancer	0.000818	0.00255	CcSEcCtD
Scopolamine—Somnolence—Fluorouracil—stomach cancer	0.000817	0.00254	CcSEcCtD
Scopolamine—Erythema—Docetaxel—stomach cancer	0.000813	0.00253	CcSEcCtD
Scopolamine—Arrhythmia—Capecitabine—stomach cancer	0.000807	0.00251	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—stomach cancer	0.000803	0.0025	CcSEcCtD
Scopolamine—Mental disorder—Capecitabine—stomach cancer	0.000792	0.00247	CcSEcCtD
Scopolamine—Feeling abnormal—Irinotecan—stomach cancer	0.000791	0.00246	CcSEcCtD
Scopolamine—Erythema—Capecitabine—stomach cancer	0.000787	0.00245	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—stomach cancer	0.000787	0.00245	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—stomach cancer	0.000786	0.00245	CcSEcCtD
Scopolamine—Pain—Fluorouracil—stomach cancer	0.000786	0.00245	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—stomach cancer	0.000772	0.0024	CcSEcCtD
Scopolamine—ABCB1—pancreas—stomach cancer	0.000767	0.0138	CbGeAlD
Scopolamine—Abdominal pain—Irinotecan—stomach cancer	0.000758	0.00236	CcSEcCtD
Scopolamine—Body temperature increased—Irinotecan—stomach cancer	0.000758	0.00236	CcSEcCtD
Scopolamine—Feeling abnormal—Fluorouracil—stomach cancer	0.000757	0.00236	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—stomach cancer	0.000749	0.00233	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—stomach cancer	0.000743	0.00231	CcSEcCtD
Scopolamine—Vision blurred—Capecitabine—stomach cancer	0.000741	0.00231	CcSEcCtD
Scopolamine—Tremor—Capecitabine—stomach cancer	0.000737	0.0023	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—stomach cancer	0.000736	0.00229	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—stomach cancer	0.000729	0.00227	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—stomach cancer	0.000728	0.00227	CcSEcCtD
Scopolamine—Body temperature increased—Fluorouracil—stomach cancer	0.000726	0.00226	CcSEcCtD
Scopolamine—Sweating—Methotrexate—stomach cancer	0.000719	0.00224	CcSEcCtD
Scopolamine—Vertigo—Capecitabine—stomach cancer	0.000707	0.0022	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—stomach cancer	0.000701	0.00218	CcSEcCtD
Scopolamine—Asthenia—Irinotecan—stomach cancer	0.000688	0.00214	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000687	0.00214	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—stomach cancer	0.000682	0.00212	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—stomach cancer	0.000681	0.00212	CcSEcCtD
Scopolamine—Dry mouth—Docetaxel—stomach cancer	0.000677	0.00211	CcSEcCtD
Scopolamine—Sweating—Epirubicin—stomach cancer	0.000672	0.00209	CcSEcCtD
Scopolamine—Confusional state—Docetaxel—stomach cancer	0.000669	0.00208	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—stomach cancer	0.000668	0.00208	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000665	0.00207	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—stomach cancer	0.000664	0.00207	CcSEcCtD
Scopolamine—ABCB1—lymphoid tissue—stomach cancer	0.000663	0.0119	CbGeAlD
Scopolamine—Oedema—Docetaxel—stomach cancer	0.000663	0.00207	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—stomach cancer	0.00066	0.00205	CcSEcCtD
Scopolamine—ABCB1—digestive system—stomach cancer	0.000655	0.0118	CbGeAlD
Scopolamine—Dry mouth—Capecitabine—stomach cancer	0.000655	0.00204	CcSEcCtD
Scopolamine—Nervous system disorder—Docetaxel—stomach cancer	0.00065	0.00203	CcSEcCtD
Scopolamine—Pruritus—Fluorouracil—stomach cancer	0.00065	0.00202	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—stomach cancer	0.000649	0.00202	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—stomach cancer	0.000648	0.00202	CcSEcCtD
Scopolamine—Confusional state—Capecitabine—stomach cancer	0.000647	0.00202	CcSEcCtD
Scopolamine—Tachycardia—Docetaxel—stomach cancer	0.000647	0.00202	CcSEcCtD
Scopolamine—Skin disorder—Docetaxel—stomach cancer	0.000644	0.00201	CcSEcCtD
Scopolamine—Oedema—Capecitabine—stomach cancer	0.000642	0.002	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—stomach cancer	0.000641	0.002	CcSEcCtD
Scopolamine—Dizziness—Irinotecan—stomach cancer	0.000634	0.00198	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—stomach cancer	0.000631	0.00196	CcSEcCtD
Scopolamine—Nervous system disorder—Capecitabine—stomach cancer	0.00063	0.00196	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—stomach cancer	0.000629	0.00196	CcSEcCtD
Scopolamine—Tachycardia—Capecitabine—stomach cancer	0.000627	0.00195	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—stomach cancer	0.000625	0.00195	CcSEcCtD
Scopolamine—Skin disorder—Capecitabine—stomach cancer	0.000624	0.00194	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—stomach cancer	0.000622	0.00194	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—stomach cancer	0.000622	0.00194	CcSEcCtD
Scopolamine—Hyperhidrosis—Capecitabine—stomach cancer	0.000621	0.00193	CcSEcCtD
Scopolamine—Hypotension—Docetaxel—stomach cancer	0.00062	0.00193	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—stomach cancer	0.000617	0.00192	CcSEcCtD
Scopolamine—Vomiting—Irinotecan—stomach cancer	0.00061	0.0019	CcSEcCtD
Scopolamine—Dizziness—Fluorouracil—stomach cancer	0.000608	0.00189	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—stomach cancer	0.000607	0.00189	CcSEcCtD
Scopolamine—Rash—Irinotecan—stomach cancer	0.000605	0.00188	CcSEcCtD
Scopolamine—Dermatitis—Irinotecan—stomach cancer	0.000604	0.00188	CcSEcCtD
Scopolamine—ABCB1—bone marrow—stomach cancer	0.000604	0.0109	CbGeAlD
Scopolamine—Headache—Irinotecan—stomach cancer	0.000601	0.00187	CcSEcCtD
Scopolamine—Hypotension—Capecitabine—stomach cancer	0.0006	0.00187	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—stomach cancer	0.000593	0.00185	CcSEcCtD
Scopolamine—Somnolence—Docetaxel—stomach cancer	0.00059	0.00184	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—stomach cancer	0.000589	0.00184	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—stomach cancer	0.000588	0.00183	CcSEcCtD
Scopolamine—Erythema—Methotrexate—stomach cancer	0.000586	0.00182	CcSEcCtD
Scopolamine—Flushing—Epirubicin—stomach cancer	0.000584	0.00182	CcSEcCtD
Scopolamine—Vomiting—Fluorouracil—stomach cancer	0.000584	0.00182	CcSEcCtD
Scopolamine—Rash—Fluorouracil—stomach cancer	0.000579	0.0018	CcSEcCtD
Scopolamine—Dermatitis—Fluorouracil—stomach cancer	0.000579	0.0018	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—stomach cancer	0.000578	0.0018	CcSEcCtD
Scopolamine—Headache—Fluorouracil—stomach cancer	0.000576	0.00179	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000575	0.00179	CcSEcCtD
Scopolamine—Fatigue—Docetaxel—stomach cancer	0.000572	0.00178	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—stomach cancer	0.000571	0.00178	CcSEcCtD
Scopolamine—Nausea—Irinotecan—stomach cancer	0.00057	0.00177	CcSEcCtD
Scopolamine—Pain—Docetaxel—stomach cancer	0.000567	0.00177	CcSEcCtD
Scopolamine—Constipation—Docetaxel—stomach cancer	0.000567	0.00177	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—stomach cancer	0.000562	0.00175	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—stomach cancer	0.000561	0.00175	CcSEcCtD
Scopolamine—Fatigue—Capecitabine—stomach cancer	0.000554	0.00172	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—stomach cancer	0.000552	0.00172	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—stomach cancer	0.000552	0.00172	CcSEcCtD
Scopolamine—Pain—Capecitabine—stomach cancer	0.000549	0.00171	CcSEcCtD
Scopolamine—Constipation—Capecitabine—stomach cancer	0.000549	0.00171	CcSEcCtD
Scopolamine—Erythema—Epirubicin—stomach cancer	0.000548	0.00171	CcSEcCtD
Scopolamine—Feeling abnormal—Docetaxel—stomach cancer	0.000547	0.0017	CcSEcCtD
Scopolamine—Nausea—Fluorouracil—stomach cancer	0.000546	0.0017	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—stomach cancer	0.000544	0.0017	CcSEcCtD
Scopolamine—ABCB1—endocrine gland—stomach cancer	0.000541	0.00973	CbGeAlD
Scopolamine—Flushing—Doxorubicin—stomach cancer	0.000541	0.00168	CcSEcCtD
Scopolamine—Feeling abnormal—Capecitabine—stomach cancer	0.000529	0.00165	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—stomach cancer	0.000526	0.00164	CcSEcCtD
Scopolamine—Body temperature increased—Docetaxel—stomach cancer	0.000524	0.00163	CcSEcCtD
Scopolamine—Abdominal pain—Docetaxel—stomach cancer	0.000524	0.00163	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—stomach cancer	0.00052	0.00162	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—stomach cancer	0.000517	0.00161	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—stomach cancer	0.00051	0.00159	CcSEcCtD
Scopolamine—Abdominal pain—Capecitabine—stomach cancer	0.000508	0.00158	CcSEcCtD
Scopolamine—Body temperature increased—Capecitabine—stomach cancer	0.000508	0.00158	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—stomach cancer	0.000507	0.00158	CcSEcCtD
Scopolamine—Agitation—Epirubicin—stomach cancer	0.000504	0.00157	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000495	0.00154	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—stomach cancer	0.000492	0.00153	CcSEcCtD
Scopolamine—ABCB1—liver—stomach cancer	0.000488	0.00877	CbGeAlD
Scopolamine—Confusional state—Methotrexate—stomach cancer	0.000482	0.0015	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—stomach cancer	0.000478	0.00149	CcSEcCtD
Scopolamine—Asthenia—Docetaxel—stomach cancer	0.000476	0.00148	CcSEcCtD
Scopolamine—Pruritus—Docetaxel—stomach cancer	0.000469	0.00146	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—stomach cancer	0.000469	0.00146	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—stomach cancer	0.000466	0.00145	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—stomach cancer	0.000464	0.00145	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000463	0.00144	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—stomach cancer	0.000462	0.00144	CcSEcCtD
Scopolamine—Asthenia—Capecitabine—stomach cancer	0.000461	0.00143	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—stomach cancer	0.000456	0.00142	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—stomach cancer	0.000456	0.00142	CcSEcCtD
Scopolamine—Pruritus—Capecitabine—stomach cancer	0.000454	0.00141	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—stomach cancer	0.000451	0.0014	CcSEcCtD
Scopolamine—Oedema—Epirubicin—stomach cancer	0.000447	0.00139	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—stomach cancer	0.000447	0.00139	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—stomach cancer	0.000439	0.00137	CcSEcCtD
Scopolamine—Dizziness—Docetaxel—stomach cancer	0.000439	0.00137	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—stomach cancer	0.000437	0.00136	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—stomach cancer	0.000435	0.00135	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—stomach cancer	0.000432	0.00135	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000429	0.00134	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—stomach cancer	0.000425	0.00132	CcSEcCtD
Scopolamine—Dizziness—Capecitabine—stomach cancer	0.000425	0.00132	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—stomach cancer	0.000422	0.00132	CcSEcCtD
Scopolamine—Vomiting—Docetaxel—stomach cancer	0.000422	0.00131	CcSEcCtD
Scopolamine—Rash—Docetaxel—stomach cancer	0.000418	0.0013	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—stomach cancer	0.000418	0.0013	CcSEcCtD
Scopolamine—Dermatitis—Docetaxel—stomach cancer	0.000418	0.0013	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—stomach cancer	0.000417	0.0013	CcSEcCtD
Scopolamine—Headache—Docetaxel—stomach cancer	0.000415	0.00129	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—stomach cancer	0.000414	0.00129	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—stomach cancer	0.000412	0.00128	CcSEcCtD
Scopolamine—Pain—Methotrexate—stomach cancer	0.000409	0.00127	CcSEcCtD
Scopolamine—Vomiting—Capecitabine—stomach cancer	0.000408	0.00127	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—stomach cancer	0.000406	0.00126	CcSEcCtD
Scopolamine—Rash—Capecitabine—stomach cancer	0.000405	0.00126	CcSEcCtD
Scopolamine—Dermatitis—Capecitabine—stomach cancer	0.000404	0.00126	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—stomach cancer	0.000404	0.00126	CcSEcCtD
Scopolamine—Headache—Capecitabine—stomach cancer	0.000402	0.00125	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—stomach cancer	0.000402	0.00125	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—stomach cancer	0.0004	0.00125	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—stomach cancer	0.000398	0.00124	CcSEcCtD
Scopolamine—Nausea—Docetaxel—stomach cancer	0.000394	0.00123	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—stomach cancer	0.000394	0.00123	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—stomach cancer	0.000387	0.0012	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—stomach cancer	0.000386	0.0012	CcSEcCtD
Scopolamine—Pain—Epirubicin—stomach cancer	0.000383	0.00119	CcSEcCtD
Scopolamine—Constipation—Epirubicin—stomach cancer	0.000383	0.00119	CcSEcCtD
Scopolamine—Nausea—Capecitabine—stomach cancer	0.000381	0.00119	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—stomach cancer	0.000378	0.00118	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—stomach cancer	0.000378	0.00118	CcSEcCtD
Scopolamine—ABCB1—lymph node—stomach cancer	0.000374	0.00673	CbGeAlD
Scopolamine—Feeling abnormal—Epirubicin—stomach cancer	0.000369	0.00115	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—stomach cancer	0.000368	0.00115	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—stomach cancer	0.000357	0.00111	CcSEcCtD
Scopolamine—Pain—Doxorubicin—stomach cancer	0.000354	0.0011	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—stomach cancer	0.000354	0.0011	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—stomach cancer	0.000354	0.0011	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—stomach cancer	0.000354	0.0011	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—stomach cancer	0.000343	0.00107	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000341	0.00106	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—stomach cancer	0.000338	0.00105	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—stomach cancer	0.000327	0.00102	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—stomach cancer	0.000327	0.00102	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—stomach cancer	0.000321	0.001	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—stomach cancer	0.000316	0.000986	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—stomach cancer	0.000316	0.000985	CcSEcCtD
Scopolamine—Vomiting—Methotrexate—stomach cancer	0.000304	0.000947	CcSEcCtD
Scopolamine—Rash—Methotrexate—stomach cancer	0.000301	0.000939	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—stomach cancer	0.000301	0.000938	CcSEcCtD
Scopolamine—Headache—Methotrexate—stomach cancer	0.000299	0.000933	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—stomach cancer	0.000297	0.000925	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—stomach cancer	0.000296	0.000921	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—stomach cancer	0.000293	0.000912	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—stomach cancer	0.000284	0.000886	CcSEcCtD
Scopolamine—Nausea—Methotrexate—stomach cancer	0.000284	0.000884	CcSEcCtD
Scopolamine—Rash—Epirubicin—stomach cancer	0.000282	0.000879	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—stomach cancer	0.000282	0.000878	CcSEcCtD
Scopolamine—Headache—Epirubicin—stomach cancer	0.00028	0.000873	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—stomach cancer	0.000274	0.000853	CcSEcCtD
Scopolamine—Nausea—Epirubicin—stomach cancer	0.000266	0.000828	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—stomach cancer	0.000263	0.00082	CcSEcCtD
Scopolamine—Rash—Doxorubicin—stomach cancer	0.000261	0.000813	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—stomach cancer	0.000261	0.000812	CcSEcCtD
Scopolamine—Headache—Doxorubicin—stomach cancer	0.000259	0.000808	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—stomach cancer	0.000246	0.000766	CcSEcCtD
Scopolamine—CHRM3—Metabolism—HMOX1—stomach cancer	3.9e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS2—stomach cancer	3.8e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HBEGF—stomach cancer	3.74e-05	0.000154	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HBEGF—stomach cancer	3.73e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HBEGF—stomach cancer	3.69e-05	0.000152	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CAV1—stomach cancer	3.69e-05	0.000152	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOA1—stomach cancer	3.68e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TYMS—stomach cancer	3.68e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS2—stomach cancer	3.64e-05	0.00015	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTM1—stomach cancer	3.63e-05	0.00015	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTT1—stomach cancer	3.62e-05	0.000149	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2A6—stomach cancer	3.58e-05	0.000147	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6R—stomach cancer	3.56e-05	0.000146	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6R—stomach cancer	3.55e-05	0.000146	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	3.54e-05	0.000146	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CAV1—stomach cancer	3.53e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	3.53e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOA1—stomach cancer	3.52e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6R—stomach cancer	3.51e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRKCB—stomach cancer	3.51e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6ST—stomach cancer	3.49e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	3.49e-05	0.000144	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKR1C3—stomach cancer	3.48e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB2—stomach cancer	3.45e-05	0.000142	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB2—stomach cancer	3.44e-05	0.000142	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ERCC2—stomach cancer	3.42e-05	0.000141	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB2—stomach cancer	3.41e-05	0.00014	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ENO1—stomach cancer	3.39e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	3.38e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	3.37e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKCB—stomach cancer	3.36e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APC—stomach cancer	3.36e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6ST—stomach cancer	3.35e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	3.34e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAPK3—stomach cancer	3.21e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APC—stomach cancer	3.21e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—RHOA—stomach cancer	3.21e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—stomach cancer	3.21e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RHOA—stomach cancer	3.2e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RHOA—stomach cancer	3.17e-05	0.000131	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	3.17e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SMAD4—stomach cancer	3.14e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SMAD4—stomach cancer	3.13e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6R—stomach cancer	3.12e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	3.11e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SMAD4—stomach cancer	3.1e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	3.1e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	3.08e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	3.07e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	3.06e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—stomach cancer	3.06e-05	0.000126	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD44—stomach cancer	3.01e-05	0.000124	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6R—stomach cancer	2.99e-05	0.000123	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FYN—stomach cancer	2.98e-05	0.000123	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FYN—stomach cancer	2.97e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAV1—stomach cancer	2.96e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOA1—stomach cancer	2.96e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FYN—stomach cancer	2.94e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	2.93e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—stomach cancer	2.93e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	2.92e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	2.92e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—KRAS—stomach cancer	2.89e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	2.82e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RHOA—stomach cancer	2.82e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	2.81e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	2.8e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGFR2—stomach cancer	2.8e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	2.8e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGFR2—stomach cancer	2.79e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—stomach cancer	2.79e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	2.79e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—KRAS—stomach cancer	2.77e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGFR2—stomach cancer	2.76e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RHOA—stomach cancer	2.7e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—stomach cancer	2.67e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	2.65e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ERBB2—stomach cancer	2.61e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—stomach cancer	2.6e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS2—stomach cancer	2.56e-05	0.000105	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.56e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS2—stomach cancer	2.55e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	2.54e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS2—stomach cancer	2.53e-05	0.000104	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTP1—stomach cancer	2.51e-05	0.000103	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ERBB2—stomach cancer	2.5e-05	0.000103	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CAV1—stomach cancer	2.48e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOA1—stomach cancer	2.48e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CAV1—stomach cancer	2.48e-05	0.000102	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—stomach cancer	2.47e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—stomach cancer	2.47e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOA1—stomach cancer	2.47e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—stomach cancer	2.46e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CAV1—stomach cancer	2.45e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOA1—stomach cancer	2.45e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	2.41e-05	9.93e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—stomach cancer	2.37e-05	9.74e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCB—stomach cancer	2.37e-05	9.73e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCB—stomach cancer	2.36e-05	9.7e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6ST—stomach cancer	2.36e-05	9.69e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—stomach cancer	2.35e-05	9.68e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—stomach cancer	2.35e-05	9.67e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6ST—stomach cancer	2.35e-05	9.66e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—stomach cancer	2.34e-05	9.63e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCB—stomach cancer	2.33e-05	9.61e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TYMS—stomach cancer	2.33e-05	9.6e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6ST—stomach cancer	2.33e-05	9.57e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	2.31e-05	9.51e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—stomach cancer	2.31e-05	9.49e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—stomach cancer	2.3e-05	9.47e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JUN—stomach cancer	2.3e-05	9.45e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APC—stomach cancer	2.26e-05	9.31e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APC—stomach cancer	2.26e-05	9.28e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—stomach cancer	2.25e-05	9.26e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—stomach cancer	2.24e-05	9.22e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—stomach cancer	2.24e-05	9.2e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APC—stomach cancer	2.23e-05	9.19e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	2.23e-05	9.17e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—stomach cancer	2.21e-05	9.07e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JUN—stomach cancer	2.2e-05	9.05e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—stomach cancer	2.17e-05	8.95e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ERCC2—stomach cancer	2.17e-05	8.92e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	2.17e-05	8.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	2.16e-05	8.89e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—stomach cancer	2.14e-05	8.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	2.14e-05	8.8e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	2.13e-05	8.78e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6R—stomach cancer	2.1e-05	8.65e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6R—stomach cancer	2.1e-05	8.62e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—stomach cancer	2.08e-05	8.57e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6R—stomach cancer	2.07e-05	8.54e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	2.06e-05	8.49e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—stomach cancer	2.06e-05	8.48e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	2.06e-05	8.46e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—stomach cancer	2.06e-05	8.46e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—stomach cancer	2.05e-05	8.43e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—stomach cancer	2.04e-05	8.38e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	2.04e-05	8.38e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—stomach cancer	2.04e-05	8.38e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—stomach cancer	2.01e-05	8.26e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—stomach cancer	1.99e-05	8.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.97e-05	8.11e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	1.97e-05	8.1e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	1.96e-05	8.08e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	1.96e-05	8.07e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—KRAS—stomach cancer	1.95e-05	8.02e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	1.95e-05	8e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	1.94e-05	7.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—KRAS—stomach cancer	1.94e-05	7.99e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—KRAS—stomach cancer	1.92e-05	7.91e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—stomach cancer	1.92e-05	7.91e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—stomach cancer	1.9e-05	7.83e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK3—stomach cancer	1.9e-05	7.81e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RHOA—stomach cancer	1.9e-05	7.81e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RHOA—stomach cancer	1.89e-05	7.79e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAV1—stomach cancer	1.88e-05	7.73e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—stomach cancer	1.88e-05	7.73e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOA1—stomach cancer	1.88e-05	7.72e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RHOA—stomach cancer	1.87e-05	7.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—stomach cancer	1.87e-05	7.71e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—stomach cancer	1.85e-05	7.63e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—stomach cancer	1.85e-05	7.6e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK3—stomach cancer	1.82e-05	7.48e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK1—stomach cancer	1.81e-05	7.43e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—stomach cancer	1.81e-05	7.43e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.79e-05	7.36e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	1.78e-05	7.34e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—stomach cancer	1.77e-05	7.28e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	1.77e-05	7.27e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	1.76e-05	7.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ERBB2—stomach cancer	1.75e-05	7.21e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ERBB2—stomach cancer	1.73e-05	7.14e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK1—stomach cancer	1.73e-05	7.12e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—stomach cancer	1.73e-05	7.12e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KRAS—stomach cancer	1.71e-05	7.02e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	1.67e-05	6.86e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—stomach cancer	1.66e-05	6.84e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	1.66e-05	6.81e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—stomach cancer	1.65e-05	6.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	1.65e-05	6.79e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	1.65e-05	6.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	1.63e-05	6.73e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KRAS—stomach cancer	1.63e-05	6.72e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	1.63e-05	6.7e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	1.62e-05	6.68e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	1.61e-05	6.61e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.58e-05	6.52e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.58e-05	6.5e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	1.57e-05	6.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.56e-05	6.44e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.55e-05	6.39e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JUN—stomach cancer	1.55e-05	6.37e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.55e-05	6.37e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JUN—stomach cancer	1.54e-05	6.35e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.53e-05	6.31e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JUN—stomach cancer	1.53e-05	6.29e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—stomach cancer	1.52e-05	6.24e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.51e-05	6.2e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.5e-05	6.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.5e-05	6.18e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	1.5e-05	6.18e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.5e-05	6.16e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.49e-05	6.12e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—stomach cancer	1.49e-05	6.11e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.48e-05	6.1e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.47e-05	6.03e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.46e-05	6.01e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—stomach cancer	1.45e-05	5.98e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—stomach cancer	1.45e-05	5.97e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.45e-05	5.95e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—stomach cancer	1.42e-05	5.85e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—stomach cancer	1.39e-05	5.72e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—stomach cancer	1.39e-05	5.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.35e-05	5.57e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.35e-05	5.55e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.34e-05	5.51e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	1.34e-05	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.34e-05	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—stomach cancer	1.33e-05	5.47e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—stomach cancer	1.32e-05	5.44e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—stomach cancer	1.3e-05	5.35e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.28e-05	5.27e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.28e-05	5.25e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	1.26e-05	5.2e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—stomach cancer	1.26e-05	5.19e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—stomach cancer	1.25e-05	5.12e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—stomach cancer	1.24e-05	5.11e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—stomach cancer	1.23e-05	5.06e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.22e-05	5.01e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.22e-05	5.01e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.21e-05	5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.21e-05	5e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.2e-05	4.95e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.2e-05	4.95e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.15e-05	4.73e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.15e-05	4.72e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.14e-05	4.67e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.06e-05	4.35e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.05e-05	4.34e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.04e-05	4.29e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—stomach cancer	1.02e-05	4.21e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—stomach cancer	1.02e-05	4.19e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—stomach cancer	1.01e-05	4.15e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—stomach cancer	9.78e-06	4.02e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—stomach cancer	9.75e-06	4.01e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—stomach cancer	9.66e-06	3.97e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—stomach cancer	9.36e-06	3.85e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—stomach cancer	9.33e-06	3.84e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—stomach cancer	9.24e-06	3.8e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—stomach cancer	8e-06	3.29e-05	CbGpPWpGaD
